OS Therapies Incorporated OSTX
0.80 USD -0.02 (-2.12%)
Regular-session close
0.79 -0.01 -1.62%
After hours · Nov 20, 4:00 PM ET
0.7901 Day range 0.8625
0.681 52-week range 2.24
- YTD
- -42.64%
- 1 year
- -50.43%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) stock rose 11.8% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $1.0 million. As per the news, the Q3…benzinga.com OS Therapies Says FDA's Shelving Of Commissioner's National Priority Voucher Has No Impact On Its Rare Pediatric Disease PRV Prospects OST-HER2 remains eligible for Priority Review Voucher ("PRV") if approved by the U.S. Food and Drug Administration's ("FDA") on or before September 30, 2029Company continues to benefit from its UK
benzinga.com OS Therapies Initiates CMAA Process With UK MHRA For Herlystic In Prevention Or Delay Of Recurrence In Fully Resected, Pulmonary Metastatic Osteosarcoma; Expects To Complete CMAA Process Later In Q4 Of 2026 US Based Clinical Stage Oncology Company Begins Critical Step Following Successful September 2026 Scientific Advice MeetingSubmission expected to be accepted in the fourth quarter of 2026Potential…
